Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector
Clinical trial NCT05432310 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05432310
- Sponsor
- University of California, Los Angeles
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-04
- Primary completion
- 2027-11-14
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.